Two Doses of COVID-19 Vaccine Appear Necessary to Protect Cancer Patients on Active Treatment
Cancer patients had a low rate of seropositivity after the first vaccine dose but not after the second dose.
Head and Neck Cancer
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Epigenetic Clock May Reveal Biological Aging After Cancer Treatment and Allow for Objective Measurement of Fatigue
Researchers found associations between epigenetic age acceleration, inflammation, and fatigue in cancer patients.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
African-American Patients Have Worse Outcomes of Oropharyngeal Cancer Regardless of Access to Medical Care
Findings suggest a need for tailored treatment in oropharyngeal squamous cell carcinoma.
Camrelizumab Plus Chemo Could Be New Standard for Recurrent, Metastatic Nasopharyngeal Carcinoma
The combination significantly prolonged progression-free survival.
Toripalimab May ‘Offer New Hope’ For Patients With Advanced Nasopharyngeal Carcinoma
Adding toripalimab to chemotherapy improved progression-free survival.
Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...